27 PATHOPHYSIOLOGY OF INCREASED ISCHAEMIC STROKE RISK IN AF 18. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke. 1990;21(1):47–51. 19. Marín F, Roldán V, Climent VE, Ibáñez A, García A, Marco P, et al. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset nonrheumatic atrial fibrillation. Heart. 2004;90(10):1162–6. 20. Yip HK, Chang LT, Sun CK, Yang CH, Hung WC, Hang CL, et al. Platelet activation in patients with chronic nonvalvular atrial fibrillation. Internal Heart Journal. 2006;47(3):371–9. 21. Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM, Andresen D, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–72. 22. Hendriks JML, De Wit R, Crijns HJGM, Vrijhoef HJM, Prins MH, Pisters R, et al. Nurseled care vs. usual care for patients with atrial fibrillation: Results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J. 2012;33(21):2692–9. 23. van den Dries CJ, van Doorn S, Rutten FH, Oudega R, van de Leur SJCM, Elvan A, et al. Integrated management of atrial fibrillation in primary care: Results of the ALL-IN cluster randomized trial. Eur Heart J. 2020;41(30):2836–44. 2
RkJQdWJsaXNoZXIy MTk4NDMw